Bipolar Disorders

Psych Congress 2020 speaker Joseph F. Goldberg, MD, details factors that could influence a patient's response to a treatment for bipolar disorder, and how clinicians can address them.

Joseph F. Goldberg, MD, explains which clinical characteristics of a patient could affect their response to a treatment for bipolar disorder.

Robert M. Post, MD, discusses the need for early intervention in bipolar disorder, steps which should be taken after a patient’s first manic episode, and factors to consider when choosing a mood stabilizer for a patient with bipolar disorder.

In this video, Christoph U. Correll, MD, of Hofstra/Northwell in New York, discusses the possible clinical applications of the combination of olanzapine and the mu-opioid antagonist samidorphan.

In this video, Christoph U. Correll, MD, discusses additional research needed on the combination of olanzapine and the mu-opioid antagonist samidorphan.

Christoph U. Correll, MD, discusses the results of the ENLIGHTEN‑2 study, which compared weight gain and cardiometabolic side effects in patients taking olanzapine and patients taking olanzapine plus samidorphan.

Psych Congress Steering Committee member Vladimir Maletic, MD, MS, shares guidelines for using antidepressants as an adjunctive treatment or monotherapy in bipolar disorder.

Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the reasons why bipolar disorder is frequently misdiagnosed. 

Vladimir Maletic, MD, MS, discusses the best tools and techniques to use to screen patients for bipolar disorder.

Vladimir Maletic, MD, MS, discusses when patients should be screened for bipolar disorder.